Expression of FGF23 in patients at different stages of chronic kidney diseases and its correction with left ventricular hypertrophy, PLSγ/calcineurin NFAT signaling pathway

Expression of FGF23 in patients at different stages of chronic kidney diseases and its correction with left ventricular hypertrophy, PLSγ/calcineurin NFAT signaling pathway

Objective To investigate the correlation of the expression of FGF23 with left ventricular hypertrophy in patients at different stages of chronic kidney diseases, and its effect on the signaling pathway for phospholipase Sγ(PLSγ)/calmodulin-activated T cell nuclear factor(NFAT). Methods The CKD patie...

Full description

Saved in:

Bibliographic Details
Main Authors:	ZHANG Yan, REN Rong, MA Yun, ZHANG Lei, MO Ying
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Nephrology 2019-01-01
Series:	Linchuang shenzangbing zazhi
Subjects:	Chronic kidney disease FGF23 Left ventricular hypertrophy PLSγ/calcineurin NFAT signaling pathway
Online Access:	http://www.lcszb.com/thesisDetails?columnId=57911933&Fpath=home&index=0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Protein phosphatases in pathological cardiac hypertrophy
by: ZHANG Xutao, et al.
Published: (2024-04-01)

The importance of whey protein levels of Klotho and fibroblast growth of factor-23 (fgf-23) as early diagnostic markers of chronic kidney damage
by: L. Yu. Milovanova, et al.
Published: (2014-06-01)

Phosphopenic form of osteomalacia in a patient with FGF23 producing tumor
by: A. S. Pushkareva, et al.
Published: (2022-05-01)

The Roxadustat (FG-4592) ameliorates tubulointerstitial fibrosis by promoting intact FGF23 cleavage
by: Jing Wang, et al.
Published: (2025-04-01)

Soluble β-Amyloid Oligomers Selectively Upregulate TRPC3 in Excitatory Neurons via Calcineurin-Coupled NFAT
by: Zhengjun Wang, et al.
Published: (2025-06-01)

Phagocytosis‐dependent activation of a TLR9–BTK–calcineurin–NFAT pathway co‐ordinates innate immunity to Aspergillus fumigatus
by: Susanne Herbst, et al.
Published: (2015-01-01)

LEFT VENTRICULAR HYPERTROPHY IN PATIENTS ON CHRONIC HAEMODIALYSIS
by: A. G. Strokov, et al.
Published: (2010-06-01)

The detection of left ventricular hypertrophy and diastolic dysfunction
by: G.R. Norton
Published: (2012-04-01)

Calcineurin as a marker of myocardial hypertrophy in children with valvular congenital heart diseases
by: A. V. Kamenshchyk, et al.
Published: (2015-06-01)

The serum levels of FGF23, sclerostin, osteoprotegerin do not explain the inverse relationship between coronary calcifications and bone mineral density evaluated using computed tomography
by: Laurence Ferrières, et al.
Published: (2025-06-01)

Hypoxia Activates FGF-23-ERK/MAPK Signaling Pathway in Ischemia-Reperfusion-Induced Acute Kidney Injury
by: Weihua Liu, et al.
Published: (2024-10-01)

Expression of fibroblast growth factor 23 (FGF23) and αKlotho in two commercial laying hen strains fed with and without dietary mineral P supplements before and after the onset of the laying phase
by: Leonie Meier, et al.
Published: (2025-11-01)

Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia
by: Wada A, et al.
Published: (2016-07-01)

Kujigamberol Inhibits IFN-γ and IL-2 mRNA Expression and NFATc2 Binding to Their Promoters in Response to a Phorbol Ester and Ionomycin Stimulation
by: Tanpitcha Yodweerapong, et al.
Published: (2025-05-01)

PERIOPERATIVE PERIOD FOLLOWING HEART TRANSPLANTATION WITH SEVERE LEFT VENTRICULAR HYPERTROPHY
by: V. N. Poptsov, et al.
Published: (2012-05-01)

Expression of FGF23 and α-KLOTHO in Normal Human Kidney Development and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
by: Patricija Bajt, et al.
Published: (2025-06-01)

Transplantation of cardiac allografts with left ventricular hypertrophy 1.5 cm and more
by: V. N. Poptsov, et al.
Published: (2019-05-01)

Endothelial eNOS deficiency causes podocyte injury through NFAT2 and heparanase in diabetic mice
by: Daisuke Katagiri, et al.
Published: (2024-11-01)

The Effect of 12 Weeks of Resistance Training on Serum Levels of Myonectin and FGF-21 in Inactive Middle-aged Men
by: Zahra Yousefvand, et al.
Published: (2024-07-01)

Left ventricular hypertrophy in arterial hypertension and arrhythmia risk
by: I. G. Fomina, et al.
Published: (1970-01-01)

Adequate post-ischemic reperfusion of the mouse brain requires endothelial NFAT5
by: Reiner Kunze, et al.
Published: (2024-12-01)

Evaluation of fibroblast growth factor 23 as a marker of severity in stable chronic obstructive pulmonary disease
by: Simarpreet Singh, et al.
Published: (2025-06-01)

Risk factors of left ventricular hypertrophy in patients with non-dialysis chronic kidney disease
by: ZHANG Zhe, et al.
Published: (2019-01-01)

In search of heart barometer—advantage of left atrial dimension over electrocardiographic indices of left ventricular hypertrophy in arterial hypertension
by: Bogusława Nowak, et al.
Published: (2023-07-01)

Influence of Echocardiographic Criteria on the Prevalence and Prognostic Implication of Left Ventricular Hypertrophy: A Nationwide Population‐Based Study
by: Anping Cai, et al.
Published: (2025-04-01)

Fibroblast Growth Factor 23 and Sarcopenia in Maintenance Haemodialysis Population
by: Limy Wong, et al.
Published: (2025-06-01)

Microglial NFAT5 aggravates neuroinflammation via mediating NLRP6 inflammasome in experimental ischemic stroke
by: Hui Gan, et al.
Published: (2025-11-01)

ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling
by: Mei Xiang, et al.
Published: (2018-09-01)

Increased left ventricular mass as a marker of left ventricular hypertrophy in normotensive type 2 DM patients
by: Moustafa Kamal Eldin Ibrahim Khalil Saad, et al.
Published: (2025-03-01)

Transcriptional regulation in the absence of inositol trisphosphate receptor calcium signaling
by: Michael Young, et al.
Published: (2024-12-01)

Relationship between parathyroid hormone and left ventricular hypertrophy in patients undergoing maintenance hemodialysis
by: WANG Li-rui, et al.
Published: (2016-01-01)

ORAI1, FGF23, PP13, palladin, and supervillin as potential biomarkers in late-onset pre-eclampsia: a comparative study in maternal and cord blood
by: Hatice Argun Atalmis, et al.
Published: (2025-07-01)

Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01)

FGF23-related hypophosphatemia in a patient with small cell lung cancer: a case report and literature review
by: Hajime Kato, et al.
Published: (2023-10-01)

THE PREVALENCE OF ARTERIAL HYPERTENSION AND THE SPECIFIC FEATURES OF DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN RADIATION-EXPOSED PERSONS
by: S. K. Kukushkin, et al.
Published: (2015-10-01)

FGF2 Mediated USP42‐PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration
by: Nanfei Yang, et al.
Published: (2025-05-01)

NFAT5: a stress-related transcription factor with multiple functions in health and disease
by: Alfredo Domínguez-López, et al.
Published: (2025-05-01)

The Role of <i>NFAT5</i> in Immune Response and Antioxidant Defense in the Thick-Shelled Mussel (<i>Mytilus coruscus</i>)
by: Yijiang Bei, et al.
Published: (2025-03-01)

Serum FGF-23 and Vitamin D Deficiency as Predictors of Metabolic Syndrome in Chronic Kidney Disease
by: Tazeen Shah, et al.
Published: (2025-04-01)

Correlation of Fibroblast Growth Factor-23 Levels with Hand Grip Strength in Twice Weekly Hemodialysis Patients
by: Aida Lydia, et al.
Published: (2020-03-01)